Impaired neurite outgrowth in the retina of a murine model of sandhoff disease

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 9, 2005, Pages 3420-3425

  Sango, Kazunori ^a   Takano, Masahiko ^b   Ajiki, Kyoko ^a   Tokashiki, Akiko ^a   Arai, Nobutaka ^a   Kawano, Hitoshi ^a   Horie, Hidenori ^c   Yamanaka, Shoji ^d  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c WASEDA UNIVERSITY   (Japan)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; COLLAGEN GEL; GANGLIOSIDE GM2; BETA N ACETYLHEXOSAMINIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE MODEL; ELECTRON MICROSCOPY; EXPLANT; HISTOPATHOLOGY; IMAGE ANALYSIS; MICROSCOPY; MOUSE; MOUSE STRAIN; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; RETINA DISEASE; SANDHOFF DISEASE; TIME; TISSUE CULTURE; ANIMAL; DRUG EFFECT; GENETICS; METABOLISM; MOUSE MUTANT; NERVE DEGENERATION; NEURITE; ORGAN CULTURE TECHNIQUE; PATHOLOGY; RETINA GANGLION CELL; ULTRASTRUCTURE;

ANIMALS; BETA-N-ACETYLHEXOSAMINIDASE; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; G(M2) GANGLIOSIDE; MICE; MICE, KNOCKOUT; NERVE DEGENERATION; NEURITES; ORGAN CULTURE TECHNIQUES; RETINAL DISEASES; RETINAL GANGLION CELLS; SANDHOFF DISEASE; TIME FACTORS;

EID: 27244433015     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0038     Document Type: Article

References (36)

1. Gravel RA, Clarke JTR, Kabak MM, Mahhuran D, Sandhoff K, Suzuki K. The GM2 gangliosidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic Basis of Inherited Disease. New York: McGraw-Hill; 1995:2839-2879.
2. Sandhoff K. The GM2 gangliosidoses and the elucidation of the β-hexosaminidase system. Adv Genet. 2001;44:67-91.
3. Cordeiro P, Hechtman P, Kaplan F. The GM2 gangliosidoses databases: allelic variation at the HEXA, HEXB, and GM2A gene loci. Genet Med. 2000;2:319-327.
4. Duke-Elder S, Dobree JH. Amaurotic family idiocy. Syst Ophthalmol. 1967;10:462-483.
5. Kivlin JD, Sanborn GE, Myers GG. The cherry-red spot in Tay-Sachs and other storage diseases. Ann Neurol. 1985;17:356-360.
6. Brownstein S, Carpenter S, Polomeno RC, Little JM. Sandhoff disease (GM2 gangliosidosis type 2): histopathology and ultrastructure of the eye. Arch Ophthalmol. 1980;98:1089-1097.
7. Yamanaka S, Johnson MD, Grinberg A, et al. Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease. Proc Natl Acad Sci USA. 1994;91:9975-9979.
8. Miklyaeva EI, Dong W, Bureau A, et al. Late onset Tay-Sachs disease in mice with targeted disruption of the Hexa gene: behavioral changes and pathology of the central nervous system. Brain Res. 2004;1001:37-50.
9. Sango K, Yamanaka S, Hoffmann A, et al. Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism. Nat Genet. 1995;11:170-176.
10. Phaneuf D, Wakamatsu N, Huang JQ, et al. Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases. Hum Mol Genet. 1996;5:1-14.
11. M2 activator deficiency manifests cerebellar pathology and motor impairment. Proc Natl Acad Sci USA. 1997;94:8138-8143.
12. Proia RL. Targeting the hexosaminidase genes: mouse models of the GM2 gangliosidoses. Adv Genet. 2001;44:225-231.
13. Jeyakumar M, Butters TD, Dwek RA, Platt FM. Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis. Neuropathol Appl Neurobiol. 2002;28:343-357.
14. Bourgoin C, Emiliani C, Kremer EJ, et al. Widespread distribution of beta-hexosaminidase activity in the brain of a Sandhoff mouse model after coinjection of adenoviral vector and mannitol. Gene Ther. 2003;10:1841-1849.
15. Yamaguchi A, Katsuyama K, Suzuki K, Kosaka K, Aoki I, Yamanaka S. Plasmid-based gene transfer ameliorates visceral storage in a mouse model of Sandhoff disease. J Mol Med. 2003;81:185-193.
16. Huang JQ, Trasler JM, Igdoura S, Michaud J, Hanai N, Gravel RA. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases. Hum Mol Genet. 1997;6:1879-1885.
17. Wada R, Tifft CJ, Proia RL. Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. Proc Natl Acad Sci USA. 2000;97:10954-10959.
18. Wu Y, Proia RL. Deletion of macrophage-inflammatory protein 1α retards neurodegeneration in Sandhoff disease mice. Proc Natl Acad Sci USA. 2004;101:8425-8430.
19. Yamaguchi A, Katsuyama K, Nagahama K, Takai T, Aoki I, Yamanaka S. Possible role of autoantibodies in the pathophysiology of GM2 gangliosidosis. J Clin invest. 2004;113:200-208.
20. Takano M, Sango K, Horie H, et al. Diabetes alters neurite regeneration from mouse retinal explants in culture. Neurosci Lett. 1999;275:175-178.
21. Takano M, Horie H, Iijima Y, Dezawa M, Sawada H, Ishikawa Y. Brain-derived neurotrophic factor enhances neurite regeneration from retinal ganglion cells in aged human retina in vitro. Exp Eye Res. 2002;74:319-323.
22. Sango K, Yamanaka S, Ajiki K, Tokashiki A, Watabe K. Lysosomal storage results in impaired survival but normal neurite outgrowth in dorsal root ganglion neurones from a mouse model of Sandhoff disease. Neuropathol Appl Neurobiol. 2002;28:23-34.
23. Padykula HA. Histochemistry and cytochemistry. In: Weiss L, ed. Histology: Cell and Tissue Biology. 5th ed. New York: Elsevier Science; 1983:88-108.
24. Hone H, Bando Y, Chi H, Takenaka T. NGF enhances neurite regeneration from nerve-transected terminals of young adult and aged mouse dorsal root ganglia in vitro. Neurosci Lett. 1991;121:125-128.
25. Takano M, Horie H. Critical period for degeneration of adult rat retinal ganglion cells and their regeneration capability after axotomy. Neurosci Lett. 1994;175:129-132.
26. Wolfe R, Bird AC. Fundus. In: Lessell S, van Dalen JTW, eds. Neuroophthalmology: a Series of Critical Surveys of the International Literature. Vol. 2. Amsterdam: Excerpta Medica; 1982:1-12.
27. Rapaport DH, Stone J. The area centralis of the retina in the cat and other mammals: focal point for function and development of the visual system. Neurosci. 1984;11:289-301.
28. Myerowitz R, Lawson D, Mizukami H, Mi Y, Tifft CJ, Proia RL. Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling. Hum Mol Genet. 2002;12:1-8.
29. Pelled D, Riebeling C, van Echten-Deckert G, Sandhoff K, Futerman AH. Reduced rates of axonal and dendritic growth in embryonic hippocampal neurones cultured from a mouse model of Sandhoff disease. Neuropathol Appl Neurobiol. 2003;29:341-349.
30. Mansour-Robaey S, Cleake DB, Wang Y-C, Bray GM, Aguayo AJ. Effects of ocular injury and the administration of brain-derived neurotrophic factor (BDNF) on the survival and regrowth of axotomized retinal ganglion cells. Proc Natl Acad Sci USA. 1994;91:1632-1636.
31. Buccoliero R, Bodennec J, van Echten-Deckert G, Sandhoff K, Futerman AH. Phospholipid synthesis is decreased in neuronal tissue in a mouse model of Sandhoff disease. J Neurochem. 2004;90:80-88.
32. Vancea JE, Campenotb RB, Vancec DE. The synthesis and transport of lipids for axonal growth and nerve regeneration. Biochem Biophys Acta. 2000;1486:84-96.
33. Barde Y-A. Edgar D, Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J. 1982;1:549-553.
34. Thanos S, Bähr M, Barde Y-A, Vanselow J. Survival and axonal elongation of adult rat retinal ganglion cells. In vitro effects of lesioned sciatic nerve and brain derived neurotrophic factor Eur J Neurosci. 1989;1:92-101.
35. Sawai H, Clarke DB, Kittlerova P, Bray GM, Aguayo AJ. Brain-derived neurotrophic factor and neurotrophin-4/5 stimulate growth of axonal branches from regenerating retinal ganglion cells. J Neurosci. 1996;16:3887-3894.
36. Cohen A, Bray GM, Aguayo AJ. Neurotrophin-4/5 increases adult rat retinal ganglion cell survival and neuntes outgrowth in vitro. J Neurobiol. 1994;25:953-959.